SCHEMBL23773237

SCHEMBL23773237

C=C(CCCOC(=O)Nc1ccc(Cl)c(C)c1)NC(=O)COc1ccc(Cl)c(F)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 2/20 0.48
▸ CYP1A2 P05177 1/20 0.46
▸ CYP2C9 P11712 1/20 0.46
▸ HPGD P15428 1/20 0.46
▸ CYP2C19 P33261 1/20 0.46
▸ RAB9A P51151 1/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ MAPT P10636 5/20 0.44
▸ ALDH1A1 P00352 2/20 0.44
▸ LMNA P02545 1/20 0.44
▸ TSHR P16473 1/20 0.44
▸ MAPK1 P28482 1/20 0.44
▸ POLB P06746 3/20 0.44
▸ ATF4 P18848 1/20 0.44
▸ RXFP1 Q9HBX9 1/20 0.43
▸ SENP2 Q9HC62 1/20 0.42
▸ GAA P10253 1/20 0.41
▸ MEN1 O00255 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ ALPL P05186 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23773254 0.92 ATF4 (0.46) NPC1CYP1A2CYP2C9HPGDCYP2C19
SCHEMBL23773238 0.91 ATF4 (0.45) NPC1CYP1A2CYP2C9HPGDCYP2C19
SCHEMBL23773242 0.88 KMT2A (0.43) NPC1CYP1A2CYP2C9HPGDCYP2C19
SCHEMBL23773278 0.85 MEN1 (0.43) NPC1CYP1A2CYP2C9HPGDCYP2C19
SCHEMBL23773227 0.84 HPGD (0.51) NPC1CYP1A2CYP2C9HPGDCYP2C19
SCHEMBL23773257 0.81 MEN1 (0.43) NPC1CYP1A2CYP2C9HPGDCYP2C19
SCHEMBL23773246 0.79 KMT2A (0.46) NPC1CYP1A2CYP2C9HPGDCYP2C19
SCHEMBL22669453 0.79 ATF4 (0.51) NPC1RAB9AATF4MEN1KMT2A
SCHEMBL23773091 0.77 LMNA (0.45) NPC1CYP1A2HPGDCYP2C19RAB9A
SCHEMBL25797240 0.75 ATF4 (0.48) ALDH1A1LMNAATF4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210253528-A1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2021-08-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210253528-A1 CHEMICAL COMPOUNDS ATF4, EIF2AK4, ATF1 NPC1 62/4885CYP1A2 2248/4885CYP2C9 3039/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback